Safety, tolerability and pharmacokinetics of multiple ascending doses of AZD8871 in healthy subjects

Trial Identifier: D6640C00003
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT02814656
Start Date: June 2016
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United Kingdom London, United Kingdom